Genome Engineering @CRISPR-Tech
Turn on notifications
Flag as spam
"Dear Investors, Here is your monthly update for June 2018 The CRISPR-Tech CopyFund is a thematic investment portfolio, which means its strategy is based on a particular investment theme, in this case selecting bio-tech or pharmateutical stocks focusing on CRISPR-Technology. This CopyFund’s portfolio is built by eToro’s investment committee. The S&P500 is currently up 2.6% this year. This CopyFund’s portfolio is currently up 4%, outperforming the index by almost 100%. This month was an average performing month for the CopyFund in terms of profit, closing in a slight drawdown. This CopyFund is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. The risk decreased for this CopyFund over last month. There were no quarterly earnings reports released this past month, which may lead to market volatility. As this is as a relatively emerging market and some of the stocks have a smaller market cap compared to others, increaed volatility in this portfolio is possible. Increased risk, can mean larger swings both ways in terms of profit and loss. Please bear this in mind. If you are planning to add funds to your existing investment, you can do so by closing your current investment and reopen it with your desired investment amount. We shall soon be opening some new CopyFunds for investment, feel free to to add the <a href="/people/sharptraders" class="e-link">@SharpTraders</a> CopyFund to your watchlist, if you are interested in further diversifying your portfolio. Please remember past performance is not indicative of any future performance. <a href="/markets/ntla" class="e-link">$NTLA (Intellia Therapeutics Inc)</a>, <a href="/markets/mrk" class="e-link">$MRK (Merck)</a>, <a href="/markets/clls" class="e-link">$CLLS (Cellectis SA)</a>, <a href="/markets/edit" class="e-link">$EDIT (Editas Medicine Inc)</a>, <a href="/markets/a" class="e-link">$A (Agilent Technologies Inc)</a>, <a href="/markets/sgmo" class="e-link">$SGMO (Sangamo Biosciences Inc)</a>, <a href="/markets/regn" class="e-link">$REGN (Regeneron Pharmaceuticals)</a> " ... Show More